NMPA Approval

Ranibizumab Injections

Approval Number

国药准字SJ20170004

Registration Date

September 16, 2021

Previous Approval Numbers

S20170004

Drug Information

Generic Name

雷珠单抗注射液

Trade Name

诺适得

Dosage Form

注射剂

Strength

10mg/ml,每瓶装量0.20ml

Drug Type

生物制品

Registration Date

September 16, 2021

Expiry Date

September 15, 2026

Company Address

6343 Risch, Switzerland

Company Address

Schaffhauserstrasse 4332 Stein, Switzerland

Empowering clinical research with data-driven insights and AI-powered tools.

雷珠单抗注射液 - NMPA 批准文号 | MedPath